Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

Share Price Information for Deltex Medical (DEMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.145
Bid: 0.13
Ask: 0.16
Change: 0.00 (0.00%)
Spread: 0.03 (23.077%)
Open: 0.145
High: 0.145
Low: 0.145
Prev. Close: 0.145
DEMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

18 Mar 2015 07:00

RNS Number : 7171H
Deltex Medical Group PLC
18 March 2015
 

Deltex Medical Group plc("Deltex Medical" or "the Company")

Director/PDMR Shareholding

 

18 March 2015 - Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring ("ODM"), announces that two Directors purchased shares in the Company.

 

Tim Irish, non-executive Director, notified the Company on 17 March 2015 of the purchase of 1,000,000 Ordinary Shares at a price of 6.475 pence per Ordinary Share. As a result Mr Irish's shareholding totals 2,848,484 ordinary shares (representing 1.34 per cent. of the issued share capital of Deltex Medical).

 

Paul Mitchell, Finance Director, notified the Company on 17 March 2015 of the purchase of 145,019 Ordinary Shares at an average price of 6.86 pence per Ordinary Share. As a result Mr Mitchell's shareholding totals 654,831 ordinary shares (representing 0.31 per cent. of the issued share capital of Deltex Medical).

 

For further information, please contact:-

 

Deltex Medical Group plc

01243 774 837

investorinfo@deltexmedical.com

Nigel Keen, Chairman

Ewan Phillips, Chief Executive

Paul Mitchell, Finance Director

Barry Curtis, Company Secretary

Nominated Adviser & Broker

Arden Partners plc

020 7614 5900

Chris Hardie

 

Joint Broker

Zeus Capital Limited

Dominic Wilson

John Goold

 

 

 

020 7533 7727

 

Financial Public Relations

Newgate

020 7653 9850

Tim Thompson

Robyn McConnachie

Ed Treadwell

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLFFILVVIDLIE
Date   Source Headline
24th Oct 20177:00 amRNSUS launch of TrueVue(TM) system
3rd Oct 20177:00 amRNSNew US hospital account
25th Sep 20177:00 amRNSShare Options
21st Sep 20177:00 amRNSRelease and first sale of HD-ICG in France
11th Sep 20177:00 amRNSInterim Results
31st Aug 20177:00 amRNSNotice of Interim Results
31st Aug 20177:00 amRNSInvestor Event
2nd Aug 201712:59 pmRNSHolding(s) in Company
28th Jul 201711:10 amRNSHolding(s) in Company
27th Jul 20175:24 pmRNSHolding(s) in Company
21st Jul 20177:01 amRNSShare placing
21st Jul 20177:00 amRNSPre-close Trading Update
13th Jun 20179:30 amRNSDirector/PDMR Shareholding
9th Jun 20171:25 pmRNSResult of AGM
9th Jun 20177:00 amRNSExcellent Results from New Trial
9th Jun 20177:00 amRNSAGM Statement
31st May 20177:00 amRNSPatent Grant
26th May 20177:00 amRNSLaunch of ODMV+ system for veterinary anaesthesia
4th May 20177:00 amRNSNew Functionality on CardioQ-ODM+ Monitor Platform
3rd May 20172:20 pmRNSExercise of Options
3rd May 20172:15 pmRNSPublication of Annual Report & Notification of AGM
27th Apr 20177:01 amRNSDeltex awarded EU Horizon 2020 Phase 1 grant
27th Apr 20177:00 amRNSResults for the year ended 31 December 2016
20th Apr 201712:25 pmRNSInvestor open day and notice of results
4th Apr 201711:51 amRNSExercise of Options
28th Mar 20176:05 pmRNSHolding(s) in Company
22nd Mar 20177:15 amRNSGrant of Options
22nd Mar 20177:00 amRNSShare Issues
23rd Feb 20177:00 amRNSNew Monitor Sales in USA and UK
25th Jan 20177:00 amRNSSouth Korean broadens ODM reimbursement
18th Jan 20177:00 amRNSTwo additional US platform programme accounts
18th Jan 20177:00 amRNSTrading Update
30th Nov 20167:00 amRNSAdditional US platform programme account
4th Nov 20167:00 amRNSNHS hospital invests in ODM equipment
8th Sep 20167:00 amRNSThree new US platform programme accounts
8th Sep 20167:00 amRNSInterim results
15th Aug 201611:10 amRNSHolding(s) in Company
15th Jul 20164:00 pmRNSHolding(s) in Company
11th Jul 20167:00 amRNSResults from head to head trial presented
8th Jul 20167:00 amRNSPre-close Trading Update
1st Jul 20168:19 amRNSShare Subscription
17th Jun 20164:10 pmRNSDirector/PDMR Shareholding
9th Jun 20167:00 amRNSTwo new accounts added to US platform programme
1st Jun 20167:00 amRNSODM adopted into clinical guidelines in Spain
12th May 20161:10 pmRNSResult of AGM
12th May 20169:30 amRNSDirector/PDMR Shareholding
12th May 20167:01 amRNSTwo US accounts added to platform programme
12th May 20167:00 amRNSAGM Statement
4th May 20167:00 amRNSEnhanced performance TruFlow probe launched in UK
20th Apr 20163:25 pmRNSPosting of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.